Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 626.00
Bid: 622.00
Ask: 628.00
Change: 4.00 (0.64%)
Spread: 6.00 (0.965%)
Open: 630.00
High: 638.00
Low: 624.00
Prev. Close: 622.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bloomsbury playwright Jon Fosse wins Nobel Prize

9 Oct 2023 13:00

RNS Number : 4421P
Bloomsbury Publishing PLC
09 October 2023
 

 

Bloomsbury playwright Jon Fosse wins Nobel Prize in Literature

 

 

9 October, LONDON: Bloomsbury, the leading independent publisher, is pleased to announce that its author Jon Fosse, the Norwegian playwright, has won the 2023 Nobel Prize in literature "for his innovative plays and prose which give voice to the unsayable."

 

According to the citation of the Nobel committee, "his immense oeuvre, written in Norwegian Nynorsk and spanning a variety of genres consists of a wealth of plays, novels, poetry collections, essays, children's books and translations. While he is today one of the most widely performed playwrights in the world, he has also become increasingly recognised for his prose."

 

Jon Fosse has won many European awards and in 2007 he was made a Knight in France's National Order of Merit. He has written 40 plays, performed around the world in different languages, including the Septology series of novels, Aliss at the Fire, Melancholy and A Shining.

 

Winning the 2023 Nobel Prize for Literature, Jon Fosse becomes the 8th Nobel-Prize winning writer from Bloomsbury's imprint Methuen Drama, joining Peter Handke, Dario Fo, Toni Morrison, Wole Soyinka, Luigi Pirandello, John Galsworthy and George Bernard Shaw.

 

Fosse's first English language play collection was published by Oberon Books, acquired by Bloomsbury in 2019, which has now published six collections of his plays, alongside single playtexts including I Am The Wind and The Dead Dogs to coincide with major premiere productions in London.

 

Nigel Newton, Chief Executive of Bloomsbury, commented: "Jon Fosse's remarkable body of dramatic work was fiercely championed by Oberon Books, now part of Methuen Drama, within the Bloomsbury Academic division, since the publication of his first English language play collection in 2002. Since then, we have published five further anthologies, totalling over 30 plays and a number of standalone translations and adaptations by some of the world's most successful contemporary dramatists. While he is one of the most-performed writers in Europe, his dramatic canon is less well-known on U.K. stages and we hope that with this historic win, the English speaking theatre community will discover and fall for his unique linguistic style, poetic naturalism and formally inventive work that manages to be both existential and life-affirming."

 

 

-ENDS-

 

For further information please contact:

 

Hudson Sandler

 

+44 (0) 20 7796 4133

Dan de Belder/Emily Brooker

 

bloomsbury@hudsonsandler.com

 

 

Bloomsbury Publishing Plc

Bloomsbury is a leading independent publisher of fiction, non-fiction, children's, specialist, academic and professional titles, listed on the London Stock Exchange. It is one of the few publishers with a portfolio that includes both general and academic publishing. Bloomsbury's ambitious growth story has seen the Group become a significant global publisher with offices in the UK, US, Australia and India.

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUPGUWUUPWGGB
Date   Source Headline
23rd Mar 201010:43 amRNSAdditional Listing
9th Mar 201010:53 amRNSNotice of Results
18th Jan 20105:59 pmRNSDirector/PDMR Shareholding
18th Jan 201012:24 pmRNSHolding(s) in Company
14th Jan 20107:00 amRNSTrading Statement
27th Nov 200911:48 amRNSHolding(s) in Company
12th Nov 20099:21 amRNSHolding(s) in Company
12th Nov 20099:17 amRNSHolding(s) in Company
10th Nov 20091:41 pmRNSHolding(s) in Company
9th Nov 200912:14 pmRNSHolding(s) in Company
4th Nov 20095:35 pmRNSHolding(s) in Company
2nd Nov 20099:57 amRNSHolding(s) in Company
23rd Oct 200912:25 pmRNSHolding(s) in Company
23rd Oct 200912:09 pmRNSHolding(s) in Company
15th Oct 20097:00 amRNSInterim Management Statement
28th Sep 20093:36 pmRNSDirector/PDMR Shareholding
27th Aug 20097:00 amRNSHalf Yearly Report
25th Aug 20092:06 pmRNSHolding(s) in Company
7th Aug 20099:30 amRNSNotice of Results
22nd Jul 20095:09 pmRNSHolding(s) in Company
16th Jul 20093:02 pmRNSBlocklisting Interim Review
16th Jul 20093:02 pmRNSBlocklisting Interim Review
16th Jul 20093:01 pmRNSBlocklisting Interim Review
16th Jul 20093:00 pmRNSBlocklisting Interim Review
16th Jul 20092:58 pmRNSBlocklisting Interim Review
16th Jul 20092:58 pmRNSBlocklisting Interim Review
16th Jul 200911:54 amRNSHolding(s) in Company
16th Jul 200911:32 amRNSBlocklisting Six Monthly Return
16th Jul 200911:30 amRNSBlocklisting Six Monthly Return
9th Jul 20096:18 pmRNSHolding(s) in Company
1st Jul 20097:00 amRNSAcquisition
18th Jun 200912:03 pmRNSHolding(s) in Company
8th Jun 200911:58 amRNSHolding(s) in Company
29th May 20094:36 pmRNSResult of AGM
15th May 20097:00 amRNSInterim Management Statement
14th May 20096:06 pmRNSHolding(s) in Company
13th May 20094:35 pmRNSPrice Monitoring Extension
8th May 20092:49 pmRNSHolding(s) in Company
6th May 20094:40 pmRNSSecond Price Monitoring Extn
6th May 20094:35 pmRNSPrice Monitoring Extension
5th May 20094:12 pmRNSHolding(s) in Company
28th Apr 20096:21 pmRNSHolding(s) in Company
24th Apr 20093:42 pmRNSHolding(s) in Company
24th Apr 20093:40 pmRNSHolding(s) in Company
20th Apr 20093:34 pmRNSHolding(s) in Company
9th Apr 200911:27 amRNSHolding(s) in Company
3rd Apr 20094:17 pmRNSHolding(s) in Company
1st Apr 200910:43 amRNSDividend Record Date
31st Mar 20097:00 amRNSFinal Results
13th Mar 20094:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.